Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan

Wei Jei Lee, Hsin Hung Chen, Weu Wang, Po Li Wei, Ching Mei Lin, Ming Te Huang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background and Purpose: The inverse relation between life expectancy and obesity is in large part due to multiple metabolic and cardiovascular comorbidities. Metabolic syndrome (MS) is defined as a cluster of these comorbidities. The prevalence of MS in obesity is not clear. This investigation assessed the prevalence and inter-relationships of MS with various demographic and clinical characteristics in patients with severe obesity. Methods: A total of 534 obese patients referred to a surgical center for weight reduction surgery were included in this retrospective study. Data collected included blood pressure, anthropometric measurements, and biochemical parameters associated with metabolic comorbidities and MS. The prevalence of MS in various subgroups was analyzed. Results: The frequency of metabolic comorbidities included hypertension in 29.8%, hyperglycemia in 29.0%, hyperlipidemia in 61.0%, hyperuricemia in 57.9%, and abnormal liver function in 60.9%. The presence of any of these 4 metabolic comorbidities in the absence of others was uncommon. Only 28 patients (5.2%) had no metabolic comorbidities. The criteria for MS were met 217 patients (50.7%). Patients with MS were significanly older (32. 9 years vs 29.5 years), more likely to be male (31.9% vs 20.5%) and more likely to have metabolic comorbidities compared with patients without MS. In the multivariate analysis, male gender, age, and abnormal liver function remained significantly associated with the development of MS, while body mass index (BMI) was not. Conclusions: Metabolic comorbidities were common in the obese patients referred for weight reduction surgery. The cluster of metabolic comorbidities in MS was significantly associated with male gender, and increased age but not with BMI.

Original languageEnglish
Pages (from-to)459-464
Number of pages6
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume102
Issue number7
Publication statusPublished - Jul 2003
Externally publishedYes

Fingerprint

Taiwan
Weight Loss
Comorbidity
Body Mass Index
Obesity
Hyperuricemia
Morbid Obesity
Liver
Life Expectancy
Hyperlipidemias
Hyperglycemia
Multivariate Analysis
Retrospective Studies
Demography
Blood Pressure
Hypertension

Keywords

  • Diabetes mellitus
  • Hyperlipidemia
  • Hypertension
  • Metabolic syndrome X
  • Morbid obesity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. / Lee, Wei Jei; Chen, Hsin Hung; Wang, Weu; Wei, Po Li; Lin, Ching Mei; Huang, Ming Te.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 102, No. 7, 07.2003, p. 459-464.

Research output: Contribution to journalArticle

@article{df865405700b429588e29f647f2d9706,
title = "Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan",
abstract = "Background and Purpose: The inverse relation between life expectancy and obesity is in large part due to multiple metabolic and cardiovascular comorbidities. Metabolic syndrome (MS) is defined as a cluster of these comorbidities. The prevalence of MS in obesity is not clear. This investigation assessed the prevalence and inter-relationships of MS with various demographic and clinical characteristics in patients with severe obesity. Methods: A total of 534 obese patients referred to a surgical center for weight reduction surgery were included in this retrospective study. Data collected included blood pressure, anthropometric measurements, and biochemical parameters associated with metabolic comorbidities and MS. The prevalence of MS in various subgroups was analyzed. Results: The frequency of metabolic comorbidities included hypertension in 29.8{\%}, hyperglycemia in 29.0{\%}, hyperlipidemia in 61.0{\%}, hyperuricemia in 57.9{\%}, and abnormal liver function in 60.9{\%}. The presence of any of these 4 metabolic comorbidities in the absence of others was uncommon. Only 28 patients (5.2{\%}) had no metabolic comorbidities. The criteria for MS were met 217 patients (50.7{\%}). Patients with MS were significanly older (32. 9 years vs 29.5 years), more likely to be male (31.9{\%} vs 20.5{\%}) and more likely to have metabolic comorbidities compared with patients without MS. In the multivariate analysis, male gender, age, and abnormal liver function remained significantly associated with the development of MS, while body mass index (BMI) was not. Conclusions: Metabolic comorbidities were common in the obese patients referred for weight reduction surgery. The cluster of metabolic comorbidities in MS was significantly associated with male gender, and increased age but not with BMI.",
keywords = "Diabetes mellitus, Hyperlipidemia, Hypertension, Metabolic syndrome X, Morbid obesity",
author = "Lee, {Wei Jei} and Chen, {Hsin Hung} and Weu Wang and Wei, {Po Li} and Lin, {Ching Mei} and Huang, {Ming Te}",
year = "2003",
month = "7",
language = "English",
volume = "102",
pages = "459--464",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan

AU - Lee, Wei Jei

AU - Chen, Hsin Hung

AU - Wang, Weu

AU - Wei, Po Li

AU - Lin, Ching Mei

AU - Huang, Ming Te

PY - 2003/7

Y1 - 2003/7

N2 - Background and Purpose: The inverse relation between life expectancy and obesity is in large part due to multiple metabolic and cardiovascular comorbidities. Metabolic syndrome (MS) is defined as a cluster of these comorbidities. The prevalence of MS in obesity is not clear. This investigation assessed the prevalence and inter-relationships of MS with various demographic and clinical characteristics in patients with severe obesity. Methods: A total of 534 obese patients referred to a surgical center for weight reduction surgery were included in this retrospective study. Data collected included blood pressure, anthropometric measurements, and biochemical parameters associated with metabolic comorbidities and MS. The prevalence of MS in various subgroups was analyzed. Results: The frequency of metabolic comorbidities included hypertension in 29.8%, hyperglycemia in 29.0%, hyperlipidemia in 61.0%, hyperuricemia in 57.9%, and abnormal liver function in 60.9%. The presence of any of these 4 metabolic comorbidities in the absence of others was uncommon. Only 28 patients (5.2%) had no metabolic comorbidities. The criteria for MS were met 217 patients (50.7%). Patients with MS were significanly older (32. 9 years vs 29.5 years), more likely to be male (31.9% vs 20.5%) and more likely to have metabolic comorbidities compared with patients without MS. In the multivariate analysis, male gender, age, and abnormal liver function remained significantly associated with the development of MS, while body mass index (BMI) was not. Conclusions: Metabolic comorbidities were common in the obese patients referred for weight reduction surgery. The cluster of metabolic comorbidities in MS was significantly associated with male gender, and increased age but not with BMI.

AB - Background and Purpose: The inverse relation between life expectancy and obesity is in large part due to multiple metabolic and cardiovascular comorbidities. Metabolic syndrome (MS) is defined as a cluster of these comorbidities. The prevalence of MS in obesity is not clear. This investigation assessed the prevalence and inter-relationships of MS with various demographic and clinical characteristics in patients with severe obesity. Methods: A total of 534 obese patients referred to a surgical center for weight reduction surgery were included in this retrospective study. Data collected included blood pressure, anthropometric measurements, and biochemical parameters associated with metabolic comorbidities and MS. The prevalence of MS in various subgroups was analyzed. Results: The frequency of metabolic comorbidities included hypertension in 29.8%, hyperglycemia in 29.0%, hyperlipidemia in 61.0%, hyperuricemia in 57.9%, and abnormal liver function in 60.9%. The presence of any of these 4 metabolic comorbidities in the absence of others was uncommon. Only 28 patients (5.2%) had no metabolic comorbidities. The criteria for MS were met 217 patients (50.7%). Patients with MS were significanly older (32. 9 years vs 29.5 years), more likely to be male (31.9% vs 20.5%) and more likely to have metabolic comorbidities compared with patients without MS. In the multivariate analysis, male gender, age, and abnormal liver function remained significantly associated with the development of MS, while body mass index (BMI) was not. Conclusions: Metabolic comorbidities were common in the obese patients referred for weight reduction surgery. The cluster of metabolic comorbidities in MS was significantly associated with male gender, and increased age but not with BMI.

KW - Diabetes mellitus

KW - Hyperlipidemia

KW - Hypertension

KW - Metabolic syndrome X

KW - Morbid obesity

UR - http://www.scopus.com/inward/record.url?scp=0347531395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347531395&partnerID=8YFLogxK

M3 - Article

C2 - 14517583

AN - SCOPUS:0347531395

VL - 102

SP - 459

EP - 464

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 7

ER -